Advanced Endo-therapeutic Procedure : Registry-based Observational Study

Official Title

Advanced Endo-therapeutic Procedure : Registry-based Observational Study at the Centre Hospitalier de l'Université de Montréal (CHUM)

Summary:

Advanced therapeutic endoscopy procedures are of increasing importance to provide minimal invasive treatment for GI diseases. The Centre Hospitalier de l'Université de Montréal as tertiary university centre is dedicated to increase the availability of therapeutic endoscopy procedures for our population in Montreal and Quebec.

Trial Description

Primary Outcome:

  • Assess the incidence of overall severe complications following the procedure
  • Assess the rate of completeness of neoplastic tissue resection
  • Assess the local recurrence of polyps
  • Assess the presence of perforation at resection site
  • Assess of the number of patients with severe bleeding complications (immediate or delayed)
  • Assess the number of patients with post-polypectomy syndrome
  • Assess the efficacy of submucosal injectate
  • Assess the number of patients with the need for surgical resection
  • Assess the number of patients with intraprocedural bleeding
Advanced therapeutic endoscopy can replace surgery for treatment of benign and malign GI diseases and the aim of this registry-based study to improve quality related to advanced therapeutic endoscopy because the trial will provides a quantitative method to assess advanced therapeutic practise at the Centre Hospitalier de l'Université de Montréal and may identify practices of low quality (possible intervention) or high quality (desired). Advanced therapeutic endoscopy procedures included for this registry-based study are endoscopic mucosal resection (EMR), Endoscopic mucosal dissection (ESD), Assessment of Polypectomy quality for colorectal adenomas/polyps, Radio frequency Ablation (RFA) and Argon Plasma Ablation (APC), and Per Oral endoscopic Myotomy (POEM).

View this trial on ClinicalTrials.gov

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.

Resources

Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society